4 Canadian Marijuana Stocks with the Highest Volatility

The Canadian marijuana stocks we’ve discovered have the greatest volatility as measured by beta

SmallCapPower | May 13, 2019: Today we have identified four Canadian marijuana stocks that have the highest volatility as measured by beta. Beta is a measure of a stock’s volatility in relation to the market. The selected cannabis stocks have a market capitalization in the range of $75 million to $7 billion.

*Market caps based on the closing price on May 10, 2019.

For Our Complete Coverage Of Canadian Marijuana Stocks Click Here    

Cronos Group Inc. (TSX:CRON) – $20.65

Cronos Group is a globally diversified and vertically-integrated cannabis company with presence in five continents. The Company operates two wholly-owned Canadian licensed producers: Peace Naturals Project Inc. and Original BC Ltd. Peace Naturals is a global health and wellness platform while Original BC is a recreational adult-use Canadian licensed producer based in Okanagan Valley, BC, which owns brands such as Cove and Spinach. Cronos Group intends to continue to rapidly expand its global footprint as it focuses on building an international iconic brand portfolio as well as developing disruptive intellectual property. On May 09, 2019, Cronos Group reported its first-quarter 2019 financial results. Net revenue surged 120% YoY to $6.5 million on the back of the launch of the adult-use recreational market in Canada.  About 1,111 kilograms were sold in first quarter 2019, representing a 122% YoY increase, driven primarily by increased cannabis production and the launch of the adult-use market in Canada. Gross profit came in at $13.3 million, with a gross margin of 206%. Net income attributable to Cronos Group was reported at $427.8 million as compared to loss of $1.1 million in Q1 2018.

  • Volatility as measured by Beta: 4.09
  • Market Cap: $6.9 Billion

InMed Pharmaceuticals Inc. (TSX:IN) – $0.465

InMed Pharmaceuticals is a biopharmaceutical company developing a proprietary biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids, as well as a pipeline of cannabinoid-based medications that target diseases with high, unmet medical needs. On March 18, 2019, the Company announced the publication of the first in a series of pending patent applications directed to the Company’s biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids.

  • Volatility as measured by Beta: 5.62
  • Market Cap: $80.0 Million

Organigram Holdings Inc. (TSXV:OGI) – $9.59

Organigram Holdings is a licensed producer of cannabis and cannabis-derived products in Canada. The Company produces high quality, premium products for medical and recreational consumers. Organigram has a strong brand portfolio, including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. On April 30, 2019, Organigram announced that it has received an expanded cultivation license from Health Canada in line with its previously-announced Phase 4A and 4B expansion plans for its Moncton Campus.

  • Volatility as measured by Beta: 5.02
  • Market Cap: $1.47 Billion

ICC International Cannabis Corp. (CSE:WRLD.U) – $0.27

ICC International Cannabis, through its subsidiaries, has operating assets and is developing a world-class platform for cultivation, extraction, formulation and distribution across the globe in the United Kingdom, Denmark, Poland, Switzerland, Germany, Macedonia, Bulgaria, Serbia, Croatia, Greece, Italy, Portugal, Malta, Colombia, Argentina, Australia, South Africa and Lesotho. On May 8, 2019, the Company entered into a distribution and cannabis processing/finishing agreement with Organic Flower Investments Group Inc. (CSE:SOW). Under the agreement, ICC will permit Organic Flower access to its European distribution network, comprised of 80,000 retail outlets and pharmacies, as well as grant Organic Flower commercial rights for cannabis processing/finishing at its EU-GMP certified facilities.

  • Volatility as measured by Beta: 4.05
  • Market Cap: $98.7 Million

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: